Ender Güçlü

Dr. Ender Güçlü

orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 October 2006 in European Archives of Oto-Rhino-Laryngology
Verified
Journal Article
Closed access
PDF file
EGEnder Güçlü
Ender Güçlü
TYTevfik Yavuz
Tevfik Yavuz
ATAbdurrahman Tokmak
Abdurrahman Tokmak
MBMustafa Behçet
Mustafa Behçet
EKElif Karali
Elif Karali
EEErol Egeli
Erol Egeli

1 June 2015 in Auris Nasus Larynx
Verified
Journal Article
Closed access
IUIlhan Unlu
Ilhan Unlu
EGEnder Güçlü
Ender Güçlü
HYHuseyin Yaman
Huseyin Yaman

1 May 2015 in American Journal of Otolaryngology
Verified
Journal Article
Closed access
IUIlhan Unlu
Ilhan Unlu
EUElif Nisa Unlu
Elif Nisa Unlu
GKGulin Gokcen Kesici
Gulin Gokcen Kesici
EGEnder Güçlü
Ender Güçlü
HYHuseyin Yaman
Huseyin Yaman
MMMehmet Memis
Mehmet Memis

4 March 2015 in European Archives of Oto-Rhino-Laryngology
Verified
Journal Article
Closed access
PDF file
IUIlhan Unlu
Ilhan Unlu
GKGulin Gokcen Kesici
Gulin Gokcen Kesici
BOBirgul Oneç
Birgul Oneç
HYHuseyin Yaman
Huseyin Yaman
EGEnder Güçlü
Ender Güçlü

10 December 2002
Verified
Journal Article
Closed access
EIEnder Inci
Ender Inci
FEFerhat Erişir
Ferhat Erişir
MAMehmet Ada
Mehmet Ada
OOOzcan Oztürk
Ozcan Oztürk
EGEnder Güçlü
Ender Güçlü
MTMurat Toprak
Murat Toprak

1 May 2008 in American Journal of Rhinology
Verified
Journal Article
Closed access
EGEnder Güçlü
Ender Güçlü
ACAbdurrahman COSKUN
Abdurrahman COSKUN
ATAbdurrahman Tokmak
Abdurrahman Tokmak
SDSadik Duran
Sadik Duran
ÖÖÖzcan Öztürk
Özcan Öztürk
EEErol Egeli
Erol Egeli
Background: Pregnancy-associated plasma protein A (PAPP-A), also known as insulin-like growth factor binding protein 4 protease, is postulated to be a new inflammatory marker in various clinical situations such as cardiovascular events, dialysis, renal transplantation, and asthma. PAPP-A also is produced in high concentrations by trophoblasts during pregnancy. Methods: We evaluated PAPP-A levels in allergic rhinitis patients and compared these with levels in healthy subjects. Thirty-one newly diagnosed allergic rhinitis patients and 29 healthy controls were included in the study. Serum PAPP-A, IgE, urea, creatinine, aspartate aminotransferase, creatine kinase (CK), CK-MB isoenzyme, total cholesterol, and triglyceride levels were determined. Results: The serum PAPP-A level was significantly higher (p = 0.013) in the allergic rhinitis group (6.1 ± 2.9 mU/L) than in the control group (4.5 ± 1.7 mU/L). The PAPP-A level in patients with allergic rhinitis and asthma (6.1 ± 2.3 mU/L) was not significantly different (p = 0.959) from that in patients with allergic rhinitis alone (6.1 ± 3.3 mU/L). The serum PAPP-A level in allergic rhinitis patients who had turbinate hypertrophy (6.9 ± 2.2 mU/L) had a tendency to be higher than that in patients who had no turbinate hypertrophy (5.5 ± 3.2 mU/L); however, this difference was not statistically significant (p = 0.151). Conclusion: Increased PAPP-A activity may be involved in the inflammation and tissue remodelling that occurs in allergic rhinitis.